(WNY News Now) – This Thursday marks World Alzheimer’s Day, emphasizing the significance of early detection as two FDA-approved treatments offer hope for those in the early stages of Alzheimer’s disease.
On September 21, 2023, the world observes World Alzheimer’s Day, shedding light on the global effort to raise awareness of Alzheimer’s disease. This year carries particular importance as, for the first time, there are two FDA-approved treatments, Leqembi and Aduhelm, designed to slow the progression of Alzheimer’s. These treatments offer individuals in the early stages of the disease more time for independence and planning for future care.
Early detection becomes paramount as these treatments are most effective in the initial stages. The Alzheimer’s Association offers guidance on recognizing early warning signs, such as memory lapses disrupting daily life, difficulties with routine tasks, and unusual personality changes. Timely diagnosis not only provides more treatment options but also opens doors to participation in clinical trials for potential new therapies.
For those seeking assistance or information, the Alzheimer’s Association provides a 24/7 Helpline (800.272.3900) to navigate crucial conversations, prepare for doctor’s appointments, and locate local resources.